SCHEMBL6409398

SCHEMBL6409398

NC(=O)C1CC(C(=O)O)CC(C(=O)O)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRR1 P24046 1/20 0.46
CYP2C19 P33261 3/20 0.39
CYP1A2 P05177 3/20 0.39
ALOX15 P16050 3/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 1/20 0.39
ABAT P80404 2/20 0.38
LMNA P02545 3/20 0.37
CYP2D6 P10635 3/20 0.37
PLG P00747 1/20 0.37
PLAT P00750 1/20 0.37
SLC1A3 P43003 1/20 0.37
SLC1A2 P43004 1/20 0.37
SLC1A1 P43005 1/20 0.37
SLC6A4 P31645 1/20 0.37
ACE P12821 1/20 0.37
TSHR P16473 2/20 0.36
PMP22 Q01453 2/20 0.36
APLNR P35414 1/20 0.36
GABRP O00591 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6409392 1.00 GABRR1 (0.46) GABRR1CYP2C19CYP1A2ALOX15KDM4E
SCHEMBL4746646 1.00 GABRR1 (0.46) GABRR1CYP2C19CYP1A2ALOX15KDM4E
SCHEMBL24035538 0.89 GABRR1 (0.42) GABRR1CYP2C19CYP1A2ALOX15KDM4E
SCHEMBL7715570 0.87 KDM4E (0.40) GABRR1ALOX15KDM4EALDH1A1LMNA
SCHEMBL7715567 0.87 KDM4E (0.40) GABRR1ALOX15KDM4EALDH1A1LMNA
SCHEMBL6542917 0.84 CYP2C19 (0.50) GABRR1CYP2C19CYP1A2ALOX15KDM4E
SCHEMBL19902117 0.84 CYP2C19 (0.50) GABRR1CYP2C19CYP1A2ALOX15KDM4E
SCHEMBL5349667 0.84 CYP2C19 (0.50) GABRR1CYP2C19CYP1A2ALOX15KDM4E
SCHEMBL23366184 0.84 CYP2C19 (0.50) GABRR1CYP2C19CYP1A2ALOX15KDM4E
SCHEMBL375124 0.84 CYP2C19 (0.50) GABRR1CYP2C19CYP1A2ALOX15KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050182138-A1 Dipeptide inhibitors of beta-secretase ELAN PHARMACEUTICALS, INC. 2005-08-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182138-A1 Dipeptide inhibitors of beta-secretase BACE1, APP, BACE2 GABRR1 1441/4885CYP2C19 4626/4885CYP1A2 4721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.